跳至主要内容
临床试验/NCT01862848
NCT01862848已完成不适用

Topical Compounded Pain Creams And Pain Perception (TOPCAPP)

Medimix Specialty Pharmacy, LLC1 个研究点 分布在 1 个国家目标入组 285 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
285
试验地点
1
主要终点
Perceived pain changes

研究概览

简要总结

To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.

详细描述

This is a prospective,observational,single center, open label study of patients that receive a combination topical compounded analgesic medication with no comparator group.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be diagnosed with an ICD9 code indicative of chronic pain.
  • Participants must be starting a new regimen of topical therapy with multiple compounded agents.
  • Participants must be expecting to receive therapy for at least 12 weeks.
  • Participants must be between 18 and 65 years of age.
  • Participants must be able to provide sound written and verbal informed consent.

排除标准

  • Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription.
  • Participants must not be pregnant or breastfeeding women.
  • Participants must not have a diagnosis of cancer within the past 5 years.

结局指标

主要结局

Perceived pain changes

时间窗: 12 Week Study [Baseline, 4,8, and 12 week evaluation]

Minimal sample size of 60 persons(maximum n=150)with a diagnosis of chronic pain (n=30 neuropathic and n=30 nociceptive primary pain-type)to determine predictors of a 30% or greater reduction of pain scores evaluated by logistic regression analyses utilizing the Brief Pain Index scores.

次要结局

  • Quality of Life(12 Weeks [Baseline,4,8, and 12 week evaluation])

研究者

发起方
Medimix Specialty Pharmacy, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验